Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

75 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Diroximel fumarate in patients with relapsing-remitting multiple sclerosis: Final safety and efficacy results from the phase 3 EVOLVE-MS-1 study.
Singer BA, Arnold DL, Drulovic J, Freedman MS, Gold R, Gudesblatt M, Jasinska E, LaGanke CC, Naismith RT, Negroski D, Oh J, Hernandez Perez MA, Selmaj K, Then Bergh F, Wundes A, Ziemssen T, Castro-Borrero W, Chen H, Levin S, Scaramozza M, Shankar SL, Wang T, Wray S. Singer BA, et al. Among authors: gudesblatt m. Mult Scler. 2023 Dec;29(14):1795-1807. doi: 10.1177/13524585231205708. Epub 2023 Oct 31. Mult Scler. 2023. PMID: 37905526 Free PMC article.
Cognitive impairment, fatigue and depression in multiple sclerosis: Is there a difference between benign and non-benign MS?
Bogaardt H, Golan D, Barrera MA, Attrill S, Kaczmarek O, Zarif M, Bumstead B, Buhse M, Wilken J, Doniger GM, Hancock LM, Penner IK, Halper J, Morrow SA, Covey TJ, Gudesblatt M. Bogaardt H, et al. Among authors: gudesblatt m. Mult Scler Relat Disord. 2023 May;73:104630. doi: 10.1016/j.msard.2023.104630. Epub 2023 Mar 21. Mult Scler Relat Disord. 2023. PMID: 36965219 Free article.
Multiple sclerosis and quality of life: The role of cognitive impairment on quality of life in people with multiple sclerosis.
Bergmann C, Becker S, Watts A, Sullivan C, Wilken J, Golan D, Zarif M, Bumstead B, Buhse M, Kaczmarek O, Covey TJ, Doniger GM, Penner IK, Hancock LM, Bogaardt H, Barrera MA, Morrow S, Gudesblatt M. Bergmann C, et al. Among authors: gudesblatt m. Mult Scler Relat Disord. 2023 Nov;79:104966. doi: 10.1016/j.msard.2023.104966. Epub 2023 Sep 3. Mult Scler Relat Disord. 2023. PMID: 37690436
Multiple Sclerosis, Fatigue, Expanded Disability Status Scale: A Cross-Sectional Exploration of Sleep Efficiency and Quantitative Sleep Parameters.
Queisi M, Attarian H, Cipriani VP, Azzi S, Kaczmarek O, Bumstead B, Buhse M, Zarif M, Golan D, Wilken J, Covey T, Gudesblatt M. Queisi M, et al. Among authors: gudesblatt m. Int J MS Care. 2024 Mar-Apr;26(2):57-60. doi: 10.7224/1537-2073.2022-118. Epub 2024 Mar 11. Int J MS Care. 2024. PMID: 38482517 Free PMC article.
Using modified Ashworth scale for assessing multiple sclerosis-associated spasticity: a high time for a paradigm shift.
MohanaSundaram A, Thukani Sathanantham S, Gudesblatt M, Ganvir S, Chinchole V, Patil B, Velayutham R. MohanaSundaram A, et al. Among authors: gudesblatt m. Ther Adv Neurol Disord. 2023 Feb 18;16:17562864231154653. doi: 10.1177/17562864231154653. eCollection 2023. Ther Adv Neurol Disord. 2023. PMID: 36814810 Free PMC article. No abstract available.
Thalamic atrophy and dysconnectivity are associated with cognitive impairment in a multi-center, clinical routine, real-word study of people with relapsing-remitting multiple sclerosis.
Zivadinov R, Bergsland N, Jakimovski D, Weinstock-Guttman B, Lorefice L, Schoonheim MM, Morrow SA, Ann Picone M, Pardo G, Zarif M, Gudesblatt M, Nicholas JA, Smith A, Hunter S, Newman S, AbdelRazek MA, Hoti I, Riolo J, Silva D, Fuchs TA, Dwyer MG, Hb Benedict R. Zivadinov R, et al. Among authors: gudesblatt m. Neuroimage Clin. 2024 Apr 27;42:103609. doi: 10.1016/j.nicl.2024.103609. Online ahead of print. Neuroimage Clin. 2024. PMID: 38718640 Free article.
Skin Biopsy Detection of Phosphorylated α-Synuclein in Patients With Synucleinopathies.
Gibbons CH, Levine T, Adler C, Bellaire B, Wang N, Stohl J, Agarwal P, Aldridge GM, Barboi A, Evidente VGH, Galasko D, Geschwind MD, Gonzalez-Duarte A, Gil R, Gudesblatt M, Isaacson SH, Kaufmann H, Khemani P, Kumar R, Lamotte G, Liu AJ, McFarland NR, Miglis M, Reynolds A, Sahagian GA, Saint-Hillaire MH, Schwartzbard JB, Singer W, Soileau MJ, Vernino S, Yerstein O, Freeman R. Gibbons CH, et al. Among authors: gudesblatt m. JAMA. 2024 Apr 16;331(15):1298-1306. doi: 10.1001/jama.2024.0792. JAMA. 2024. PMID: 38506839
Peering further into the mind's eye: combining visual evoked potential and optical coherence tomography measures enhances insight into the variance in cognitive functioning in multiple sclerosis.
Covey TJ, Golan D, Sergott R, Wilken J, Zarif M, Bumstead B, Buhse M, Kaczmarek O, Doniger GM, Penner IK, Hancock LM, Bogaardt H, Barrera MA, Morrow SA, Galetta S, Gudesblatt M. Covey TJ, et al. Among authors: gudesblatt m. J Neurol. 2024 Feb;271(2):658-673. doi: 10.1007/s00415-023-12075-5. Epub 2023 Dec 13. J Neurol. 2024. PMID: 38091086
Cognitive impairment in people with multiple sclerosis: Perception vs. performance - factors that drive perception of impairment differ for patients and clinicians.
Jackson DA, Nicholson R, Bergmann C, Wilken J, Kaczmarek O, Bumstead B, Buhse M, Zarif M, Penner IK, Hancock LM, Golan D, Doniger GM, Bogaardt H, Barrera M, Covey TJ, Gudesblatt M. Jackson DA, et al. Among authors: gudesblatt m. Mult Scler Relat Disord. 2023 Jan;69:104410. doi: 10.1016/j.msard.2022.104410. Epub 2022 Nov 13. Mult Scler Relat Disord. 2023. PMID: 36399966
75 results